by Sue Robbins | Jan 6, 2020 | Migraine
There are now a number of medications that may prevent or alleviate migraines, as well as a wearable nerve-stimulating device that can be activated by a smartphone. If you live with or work with someone who suffers from migraine, there’s something very important you...
by Sue Robbins | Jan 2, 2020 | Migraine
A new study finds that people whose sleep is fragmented during the night are at higher risk of experiencing a migraine episode not the next day, but the day after that. Share on PinterestFragmented sleep might trigger migraine 2 days later, research finds. Dr. Suzanne...
by Sue Robbins | Dec 30, 2019 | Migraine
Patients who visit urgent care centers for acute migraine often do not receive the emergency treatment as recommended according to guidelines from the American Headache Society (AHS), according to study results published in Headache. Urgent care centers are emerging...
by Sue Robbins | Dec 26, 2019 | Migraine
The FDA has approved ubrogepant (Ubrelvy; Allergan) for the acute treatment of migraine with or without aura in adults, making it the first-in-class oral calcitonin gene-related peptide (CGRP) antagonist for this indication.1 The new drug application (NDA) was...
by Sue Robbins | Dec 23, 2019 | Migraine
Aura has long been a perplexing issue in migraine. Primarily viewed as a prodromal sign of migraine in some patients some of the time, aura has been largely overlooked in clinical trials that tend to enroll patients with migraine with and without aura.1 However, new...
